Eli Lilly and Company

The current price of LLY.TO is CA$50.87 — it has increased by 1.29% since the previous close. Data as of Nov 4, 2026.

LLY.TO is up 1.19% over the past week, up 24.65% over the past month and up 30.17% over the past year. The price is above its 200-day moving average of CA$39.35.

Eli Lilly and Company has a market capitalization of CA$1.75T. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

Yes. Eli Lilly and Company pays dividends quarterly. The latest payment of CA$0.06135 per share has a payment date of Dec 17, 2026, which corresponds to a dividend yield of 0.49%.

Companies most comparable to Eli Lilly and Company include Johnson & Johnson, Gilead Sciences, Inc., Merck & Co., Inc., AbbVie Inc. and Novo Nordisk A/S.

In the latest trading session LLY.TO moved between CA$50.00 and CA$51.52, a range of 2.99% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Eli Lilly and Company shows a buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.

Over the past 52 weeks LLY.TO has traded between CA$30.67 and CA$51.66. The current price is 1.53% below its 52-week high.